** Elevance's ELV.N shares rise 6.4% to $416.03 premarket
** Insurer beats Q4 profit estimates helped in part by lower-than-expected spending on medical care for its customers
** Company reports Q4 adjusted profit of $3.84 per share, beating estimates of $3.80 per share as per data compiled by LSEG
** Reports Q4 medical loss ratio — the percentage of premiums spent on medical care — of 92.4%, compared with analysts' estimates of 92.65%
** Stock had fallen 21.8% in 2024
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。